<DOC>
	<DOCNO>NCT01046435</DOCNO>
	<brief_summary>The purpose study determine treat periodontal infection ( gum disease ) reduce marker systemic inflammation patient risk cardiovascular disease .</brief_summary>
	<brief_title>Effects Periodontal Therapy Systemic Inflammation</brief_title>
	<detailed_description>Aims : To determine effect periodontal treatment systemic marker inflammation subject risk coronary heart disease . Methods : The current study randomize , double blind clinical trial , two treatment group . Eligible participant allocate restricted randomization use minimization method treatment group control group . The treatment group receive periodontal therapy consist instruction plaque control , supra subgingival scale root planing , oral systemic metronidazole ( 250 mg ) plus amoxicillin ( 500 mg ) tid 7 day . The control group receive plaque control instruction , supragingival scale two placebo . The study plan enroll 160 participant , 80 ech arm , 6-month period . Follow-up clinic visit schedule occur every 3 month finish treatment . Baseline follow-up clinic visit include periodontal examination , blood collection medical dental history . The following biochemical marker determine baseline 3 , 6 , 9 12 month posttherapy : total , LDL HDL lipoprotein cholesterol triglyceride , glycemia , high sensitivity C-reactive protein , fibrinogen , erythrocyte sedimentation rate white blood cell count . In diabetic patient , glycosylated hemoglobin also assess . The study conduct public health center Santiago , Chile . To eligible study , participant older 35 year fulfill medical periodontal criterion . For medical criterion participant dyslipidemia , least one follow coronary heart disease risk factor : obesity , smoking , diabetes , hypertension . The periodontal inclusion criterion : history periodontal treatment , presence least 14 natural teeth , least 4 teeth interproximal site probe depth equal high 4 mm concomitant attachment loss equal high 3 mm , &gt; 30 % site bleed probe . The outcomes measure level serum C-reactive protein , fibrinogen , erythrosedimentation rate , white blood cell count.The outcome measure 0 , 3,6,9 , 6 month periodontal therapy .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Clinically diagnosis marginal periodontitis No history periodontal treatment At least 14 natural teeth present Dyslipidemia And least one follow factor : obesity diabetes smoke , hypertension Rheumatoid arthritis Any type cancer previous 2 year Pregnancy lactation Indication use antibiotic invasive procedure Use antibiotic previous three month .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>periodontitis</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>diabetes</keyword>
</DOC>